Integrated Microbiome, Metabolome, and Proteome Analysis Identifies a Novel Interplay Among Commensal Bacteria, Metabolites and Candidate Targets in Non-small Cell Lung Cancer

Overview

Journal Clin Transl Med

Publisher Wiley

Specialty General Medicine

Date 2022 Jun 23

PMID 35735103

Authors

Xiang Qian

Hong-Yan Zhang

Qing-Lin Li

Guan-Jun Ma

Zhuo Chen

Xu-Ming Ji

Chang-Yu Li

Ai-Qin Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Accumulation of evidence suggests that the gut microbiome, its specific metabolites, and differentially expressed proteins (DEPs) are related to non-small cell lung cancer (NSCLC) pathogenesis. We now report the influences of the gut microbiota, metabolites, and DEPs on the mediation of NSCLC's chronic inflammation and immune dysregulation.

Methods: We conducted 16S ribosomal RNA sequencing for the gut microbiome in healthy volunteers and NSCLC patients. Liquid chromatography-mass spectrometry (LC-MS) analysis was employed to explore differences between metabolites and DEPs in serum samples. Additionally, LC-MS-based metabolomic analysis was conducted in 40 NSCLC tissues and 40 adjacent tissues. The omics data were separately analysed and integrated by using Spearman's correlation coefficient. Then, faecal microbiota transplantation (FMT) assay was used to assess the effects of the gut microbiome and specific metabolites in mice.

Results: Faecal microbiome analysis revealed gut microflora dysbiosis in NSCLC patients with Prevotella, Gemmiger, and Roseburia significantly upregulated at the genus level. Then, we identified that nervonic acid/all-trans-retinoic acid level was negatively related to Prevotella. Additionally, a total of core 8 DEPs were selected in the proteome analysis, which mainly participated in the production of IL-8 and NF-κB pathways. CRP, LBP, and CD14 were identified as potential biomarkers for NSCLC. Transplantation of faecal microbiota from patients with NSCLC or Prevotella copri-colonized recipient in mice resulted in inflammation and immune dysregulation. In turn, nervonic acid/all-trans-retinoic acid treatment improved the phenotype of C57BL/6 mice bearing P. copri-treated Lewis lung cancer (LLC).

Conclusions: Overall, these results pointed out that P. copri-nervonic acid/all-trans-retinoic acid axis may contribute to the pathogenesis of NSCLC.

Citing Articles

Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review).

Zhang J, Feng Y, Li D, Shi D Oncol Lett. 2024; 29(1):50.

PMID: 39564373 PMC: 11574707. DOI: 10.3892/ol.2024.14796.

Improving CT scan for lung cancer diagnosis with an integromic signature.

Liao J, Dhilipkannah P, Jiang F J Biol Methods. 2024; 11(3):e99010023.

PMID: 39544186 PMC: 11557295. DOI: 10.14440/jbm.2024.0028.

A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome.

Pavelescu L, Profir M, Enache R, Rosu O, Cretoiu S, Gaspar B Int J Mol Sci. 2024; 25(19).

PMID: 39408795 PMC: 11476728. DOI: 10.3390/ijms251910467.

From pathogenesis to treatment: the impact of bacteria on cancer.

Lu J, Tong Q Front Microbiol. 2024; 15:1462749.

PMID: 39360320 PMC: 11445166. DOI: 10.3389/fmicb.2024.1462749.

Fecal microbial transplants as investigative tools in cancer.

Bohm M, Ramesh A, Pierre J, Cook K, Murphy E, Makowski L Am J Physiol Gastrointest Liver Physiol. 2024; 327(5):G711-G726.

PMID: 39301964 PMC: 11559651. DOI: 10.1152/ajpgi.00171.2024.

References

Solbach P, Chhatwal P, Woltemate S, Tacconelli E, Buhl M, Autenrieth I . Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study. Clin Infect Dis. 2020; 73(9):e2625-e2634. DOI: 10.1093/cid/ciaa871. View

Tsai C, Perng R, Chen M, Jan Y, Hung M, Ku T . Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines. J Natl Cancer Inst. 1994; 86(13):1018-20. DOI: 10.1093/jnci/86.13.1018. View

Xu J, Zhang C, Wang X, Zhai L, Ma Y, Mao Y . Integrative Proteomic Characterization of Human Lung Adenocarcinoma. Cell. 2020; 182(1):245-261.e17. DOI: 10.1016/j.cell.2020.05.043. View

Gui Q, Li H, Wang A, Zhao X, Tan Z, Chen L . The association between gut butyrate-producing bacteria and non-small-cell lung cancer. J Clin Lab Anal. 2020; 34(8):e23318. PMC: 7439349. DOI: 10.1002/jcla.23318. View

Krug K, Jaehnig E, Satpathy S, Blumenberg L, Karpova A, Anurag M . Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy. Cell. 2020; 183(5):1436-1456.e31. PMC: 8077737. DOI: 10.1016/j.cell.2020.10.036. View

Wang Z, Zhang L, Wan Z, He Y, Huang H, Xiang H . Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells. Pathol Oncol Res. 2018; 26(1):209-216. DOI: 10.1007/s12253-018-0415-7. View

Drago L . and Microbiota in Rheumatoid Arthritis: Fully Convincing Evidence?. J Clin Med. 2019; 8(11). PMC: 6912755. DOI: 10.3390/jcm8111837. View

Erawijantari P, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T . Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut. 2020; 69(8):1404-1415. PMC: 7398469. DOI: 10.1136/gutjnl-2019-319188. View

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

10.

Chalubinska-Fendler J, Fendler W, Spych M, Wyka K, Luniewska-Bury J, Fijuth J . Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer. Biomed Rep. 2016; 5(4):450-454. PMC: 5038356. DOI: 10.3892/br.2016.739. View

11.

Liu F, Li J, Guan Y, Lou Y, Chen H, Xu M . Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer. Int J Biol Sci. 2019; 15(11):2381-2392. PMC: 6775324. DOI: 10.7150/ijbs.35980. View

12.

Zhuo M, An T, Zhang C, Wang Z . Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients. Front Oncol. 2020; 10:1584. PMC: 7476634. DOI: 10.3389/fonc.2020.01584. View

13.

Mates J, Campos-Sandoval J, De Los Santos-Jimenez J, Marquez J . Dysregulation of glutaminase and glutamine synthetase in cancer. Cancer Lett. 2019; 467:29-39. DOI: 10.1016/j.canlet.2019.09.011. View

14.

Pascua S, McGahey G, Ma N, Wang J, Digman M . Caffeine and Cisplatin Effectively Targets the Metabolism of a Triple-Negative Breast Cancer Cell Line Assessed via Phasor-FLIM. Int J Mol Sci. 2020; 21(7). PMC: 7177700. DOI: 10.3390/ijms21072443. View

15.

Zhang Y, Yuan S, Pu J, Yang L, Zhou X, Liu L . Integrated Metabolomics and Proteomics Analysis of Hippocampus in a Rat Model of Depression. Neuroscience. 2017; 371:207-220. DOI: 10.1016/j.neuroscience.2017.12.001. View

16.

Li B, Zhu L, Lu C, Wang C, Wang H, Jin H . circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021; 12(1):295. PMC: 7804955. DOI: 10.1038/s41467-020-20527-z. View

17.

Roedig H, Nastase M, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C . Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol. 2018; 77:4-22. DOI: 10.1016/j.matbio.2018.05.006. View

18.

Du T, Li H, Fan Y, Yuan L, Guo X, Zhu Q . The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun. 2019; 10(1):2914. PMC: 6606649. DOI: 10.1038/s41467-019-10824-7. View

19.

Xu H, Wang L, Shi B, Hu L, Gan C, Wang Y . Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation. Biomed Pharmacother. 2020; 129:110441. DOI: 10.1016/j.biopha.2020.110441. View

20.

Larsen J . The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017; 151(4):363-374. PMC: 5506432. DOI: 10.1111/imm.12760. View